Persistently Elevated Serum Interleukin-6 Predicts Mortality Among Adults Receiving Combination Antiretroviral Therapy in Botswana: Results from a Clinical Trial-Reference-Cited by-同舟云学术

Persistently Elevated Serum Interleukin-6 Predicts Mortality Among Adults Receiving Combination Antiretroviral Therapy in Botswana: Results from a Clinical Trial

Published:2013-07 Issue:7 Volume:29 Page:993-999
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

McDonald Bethan¹²,Moyo Sikhulile²,Gabaitiri Lesego³,Gaseitsiwe Simani¹²,Bussmann Hermann¹²,Koethe John R.⁴,Musonda Rosemary¹²,Makhema Joseph¹²,Novitsky Vladimir¹²,Marlink Richard G.¹²,Wester C. William¹²⁴,Essex Max¹²

Affiliation:

1. Harvard School of Public Health AIDS Initiative, Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts.

2. Botswana–Harvard AIDS Institute, Gaborone, Botswana.

3. Department of Statistics, University of Botswana, Gaborone, Botswana.

4. Department of Medicine, Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, Tennessee.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2012.0309

Reference33 articles.

1. The Survival Benefits of AIDS Treatment in the United States

2. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania